Glenmark Pharma's arm recalls three drugs from US market due to odd smell

24 May 2013 Evaluate

Glenmark Generics Inc, USA, a subsidiary of Glenmark Pharmaceuticals, is in process of recalling multiple lots of three of its drugs from the US market due to complaints related to an off-odour described as moldy, musty or fishy in nature. The recall of the three drugs was initiated under Class-III which FDA defined as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

As per US Food and Drug Administration (USFDA), the drug major has initiated voluntary recall of its Gabapentin Tablets 600mg, 500-count bottle and 800 mg, 500- count bottle; Pravastatin Sodium Tablets 40 mg, 90-count bottle; and Topiramate Tablets 200 mg, 60-count bottles from the US market following the identification of the problem. The firm has been recalling 33,138 bottles and 9,278 bottles of Gabapentin Tablets 600mg and 800 mg, respectively, 246,528 bottles of Pravastatin and 9624 bottles of Topiramate Tablets.

The problem has been caused due to bottles supplied by one HDPE bottle supplier whose services have been terminated by the company. This recalls will however have insignificant financial implications on the company.

Glenmark Pharma Share Price

1962.50 -3.55 (-0.18%)
17-Dec-2025 10:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.65
Dr. Reddys Lab 1271.95
Cipla 1496.95
Zydus Lifesciences 917.95
Lupin 2118.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×